FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090211537> ?p ?o ?g. }

• W2090211537 endingPage "1810" @default.
• W2090211537 startingPage "1810" @default.
• W2090211537 abstract "Up to three quarters of patients with gastroesophageal reflux disease (GERD) have symptoms, such as heartburn, but no macroscopic evidence of erosive esophagitis, making symptomatic GERD a common clinical problem in the primary care setting.To compare the efficacy and safety of omeprazole, 20 mg once daily; omeprazole, 10 mg once daily; and placebo in the treatment of symptomatic GERD without erosive esophagitis.Patients with a history of heartburn (> or =12 months) and episodes of moderate to severe heartburn on 4 or more of the 7 days before endoscopy were eligible to participate in this 4-week, randomized, double-blind, placebo-controlled trial. The absence of erosive esophagitis was established through endoscopy. Eligible patients were randomized to 1 of 3 treatment groups: omeprazole, 20 mg once daily; omeprazole, 10 mg once daily; or placebo. Patients were assessed at weeks 2 and 4. The efficacy of omeprazole for the treatment of heartburn was determined mainly through the following diary card data: daily resolution of heartburn and complete resolution of heartburn every day during 1 week of treatment. The efficacy of omeprazole for the treatment of acid regurgitation, dysphagia, epigastric pain, and nausea was also assessed.Of 359 randomized patients, 355 were included in the statistical analysis (intention-to-treat population). Daily proportions of patients with no heartburn were consistently greater in the 20-mg omeprazole group (62%, day 7; 74%, day 27) than in the 10-mg omeprazole group (41%, day 7; 49%, day 27) or the placebo group (14%, day 7; 23%; day 27). Complete resolution of heartburn every day during the last treatment week was significantly (P< or =.002) higher in the 20-mg omeprazole group (48%) than in the 10-mg omeprazole (27%) or placebo (5%) group. Omeprazole was significantly (P< or =.003) more effective than placebo for the treatment of acid regurgitation, dysphagia, epigastric pain, and nausea.Patients with symptomatic GERD require profound acid suppression to achieve symptomatic relief. Omeprazole, 20 mg once daily, was superior to omeprazole, 10 mg once daily, and to placebo in providing early and sustained resolution of heartburn, as well as treatment of other troublesome GERD symptoms." @default.
• W2090211537 created "2016-06-24" @default.
• W2090211537 creator A5011290043 @default.
• W2090211537 creator A5019112797 @default.
• W2090211537 creator A5061723576 @default.
• W2090211537 creator A5084545705 @default.
• W2090211537 creator A5087680412 @default.
• W2090211537 date "2000-06-26" @default.
• W2090211537 modified "2023-10-10" @default.
• W2090211537 title "Efficacy of Omeprazole for the Treatment of Symptomatic Acid Reflux Disease Without Esophagitis" @default.
• W2090211537 cites W1244318807 @default.
• W2090211537 cites W1980790924 @default.
• W2090211537 cites W199030824 @default.
• W2090211537 cites W1992109982 @default.
• W2090211537 cites W1996358629 @default.
• W2090211537 cites W2007097175 @default.
• W2090211537 cites W2016826323 @default.
• W2090211537 cites W2022848113 @default.
• W2090211537 cites W2025841048 @default.
• W2090211537 cites W2030535593 @default.
• W2090211537 cites W2032521184 @default.
• W2090211537 cites W2033585031 @default.
• W2090211537 cites W2036589016 @default.
• W2090211537 cites W2037099447 @default.
• W2090211537 cites W2038481694 @default.
• W2090211537 cites W2048411958 @default.
• W2090211537 cites W2050977114 @default.
• W2090211537 cites W2053253142 @default.
• W2090211537 cites W2060152915 @default.
• W2090211537 cites W2069160344 @default.
• W2090211537 cites W2072166021 @default.
• W2090211537 cites W2089585274 @default.
• W2090211537 cites W2092927895 @default.
• W2090211537 cites W2093226163 @default.
• W2090211537 cites W2094402367 @default.
• W2090211537 cites W2112774005 @default.
• W2090211537 cites W2113855243 @default.
• W2090211537 cites W2114865489 @default.
• W2090211537 cites W2149860264 @default.
• W2090211537 cites W2153256173 @default.
• W2090211537 cites W2161161473 @default.
• W2090211537 cites W2170274343 @default.
• W2090211537 cites W2233626609 @default.
• W2090211537 cites W2314540303 @default.
• W2090211537 cites W2408359723 @default.
• W2090211537 cites W2410533321 @default.
• W2090211537 cites W2412218730 @default.
• W2090211537 cites W2413835302 @default.
• W2090211537 cites W2435985859 @default.
• W2090211537 cites W37300155 @default.
• W2090211537 cites W85486894 @default.
• W2090211537 cites W1989745883 @default.
• W2090211537 doi "https://doi.org/10.1001/archinte.160.12.1810" @default.
• W2090211537 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10871975" @default.
• W2090211537 hasPublicationYear "2000" @default.
• W2090211537 type Work @default.
• W2090211537 sameAs 2090211537 @default.
• W2090211537 citedByCount "112" @default.
• W2090211537 countsByYear W20902115372012 @default.
• W2090211537 countsByYear W20902115372013 @default.
• W2090211537 countsByYear W20902115372014 @default.
• W2090211537 countsByYear W20902115372016 @default.
• W2090211537 countsByYear W20902115372018 @default.
• W2090211537 countsByYear W20902115372019 @default.
• W2090211537 countsByYear W20902115372022 @default.
• W2090211537 countsByYear W20902115372023 @default.
• W2090211537 crossrefType "journal-article" @default.
• W2090211537 hasAuthorship W2090211537A5011290043 @default.
• W2090211537 hasAuthorship W2090211537A5019112797 @default.
• W2090211537 hasAuthorship W2090211537A5061723576 @default.
• W2090211537 hasAuthorship W2090211537A5084545705 @default.
• W2090211537 hasAuthorship W2090211537A5087680412 @default.
• W2090211537 hasBestOaLocation W20902115371 @default.
• W2090211537 hasConcept C126322002 @default.
• W2090211537 hasConcept C142724271 @default.
• W2090211537 hasConcept C204787440 @default.
• W2090211537 hasConcept C27081682 @default.
• W2090211537 hasConcept C2776462128 @default.
• W2090211537 hasConcept C2777014526 @default.
• W2090211537 hasConcept C2777498785 @default.
• W2090211537 hasConcept C2779134260 @default.
• W2090211537 hasConcept C2779920096 @default.
• W2090211537 hasConcept C2781025758 @default.
• W2090211537 hasConcept C2908647359 @default.
• W2090211537 hasConcept C2909576783 @default.
• W2090211537 hasConcept C43270747 @default.
• W2090211537 hasConcept C71924100 @default.
• W2090211537 hasConcept C90924648 @default.
• W2090211537 hasConcept C99454951 @default.
• W2090211537 hasConceptScore W2090211537C126322002 @default.
• W2090211537 hasConceptScore W2090211537C142724271 @default.
• W2090211537 hasConceptScore W2090211537C204787440 @default.
• W2090211537 hasConceptScore W2090211537C27081682 @default.
• W2090211537 hasConceptScore W2090211537C2776462128 @default.
• W2090211537 hasConceptScore W2090211537C2777014526 @default.
• W2090211537 hasConceptScore W2090211537C2777498785 @default.
• W2090211537 hasConceptScore W2090211537C2779134260 @default.
• W2090211537 hasConceptScore W2090211537C2779920096 @default.

• next